AusDiagnostics
Sydney, Australia· Est.
Multiplexed PCR diagnostics provider delivering up to 40‑target panels for human, animal and environmental testing.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Multiplexed PCR diagnostics provider delivering up to 40‑target panels for human, animal and environmental testing.
Human Infectious DiseaseAnimal HealthApplied Testing (Agriculture & Food Safety)
Technology Platform
Proprietary MT‑PCR (Multiplexed Tandem PCR) platform enabling simultaneous detection of up to 40 targets, combined with automated extraction (MT‑Prep®) and high‑throughput instruments (UltraPlex Alliance™).
Opportunities
Expansion of multiplexed panels for emerging pathogens and antimicrobial‑resistance surveillance, plus growth in the US market through its Texas subsidiary.
Risk Factors
Intense competition from larger diagnostics firms and regulatory hurdles across multiple regions could constrain market penetration.
Competitive Landscape
Competes with Cepheid, BioFire, Luminex and Roche; differentiates through high‑multiplex capacity (up to 40 targets) and integrated extraction‑to‑result workflows.